AzTrials
AzTrials

Ileostomy - StomaNCT06914804

Stomasense: A New Route to the Proactive Detection and Management of Leaks Within Ostomy Pouches

A study testing Stomasense in people with Ileostomy - Stoma, run by University of Ulster at 1 site in United Kingdom.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

People living with an ileostomy may often experience leaks from their stoma pouches. Leakages are a highly stressful experience, so it is no surprise that worry about leaks is very common among ileostomates and this can contribute to increased anxiety and impact negatively on quality of life. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ileostomy - Stoma
What is being tested?
Stomasense
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited Kingdom
Study dates
14 Apr 2025to 31 Jan 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Living with an ileostomy
  • ≥1.5-years post-operative
  • Aged 18+ years
  • Experiencing frequent leaks (i.e., more than once per week)
  • Males and females (not currently pregnant/lactating)
  • Self-manging their own stoma
Show all 9Show fewer
  • Access to computer / mobile device for survey completion
  • No learning or other disabilities
  • Have never used / trialled other leak detection systems

Who cannot join

  • Never had an ileostomy,
  • Individuals with previous ileostomy or ostomy (colostomy or urostomy)
  • <1.5-year post-operative
  • <18 years
  • Do not experience frequent leaks (i.e., less than once per week)
  • Adults with learning or other disabilities
  • Have previously used other leak detection systems
  • Pregnant/lactating female

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United Kingdom1 site
  • Ulster University, Human Intervention Studies Unit

    Coleraine, Co. Derry, BT521SA

Other trials in United Kingdom

About this study

People living with an ileostomy may often experience leaks from their stoma pouches. Leakages are a highly stressful experience, so it is no surprise that worry about leaks is very common among ileostomates and this can contribute to increased anxiety and impact negatively on quality of life. Ileostomates will make changes to their lifestyle to minimise the occurrence of leaks; they may avoid travelling long distances, steer clear of busy social events and often restrict certain food(s) and / or drink(s). The latter stands in the way of achieving a healthy balanced diet and can put ileostomates at risk of developing nutritional deficiencies.

Researchers at ulster university have developed a leak sensor device which can be worn unobtrusively alongside any stoma pouch. The device can detect the early stages of a leak from the stoma bag and alerts the user, meaning they are able to change their pouch before it's too late. Participants will be asked to trial 2 versions of the device, each over a 2-week period. At the beginning and end of each period participants will complete a series of questionnaires to allow the research team to determine device efficacy and impact on quality of life. Food diaries will also be completed by participants to give an indication of how dietary intake can impact the incidence of pouch leakage.

Read the detailed description

Surgical diversion of the bowel to create an opening in the abdomen (stoma) is a common procedure in the treatment of various gastrointestinal conditions; 21 000 stomas are created in the UK each year and it is estimated that 176 000 - 205 000 individuals in the UK are living with a stoma. This is a life-changing operation which requires significant physical and psychological adaptation particularly as bowel/bladder content is collected in a disposable pouch that adheres to the abdomen. Leakage, especially in public, is a constant worry resulting in decreased social interactions, increased anxiety and depression and can have a tremendous impact on family and work life. The extent of the problem was confirmed by the Ostomy Life Study (2015) which surveyed some 4000 ostomates from 11 different countries and found the majority (91%) of participants reported that leakage of the pouch was a concern with 69% confirming that it was their prime worry and greatly impacted on their quality of life (QoL). Leakage events are very traumatic emotionally and will impact an individual's practical management of their ostomy; stoma effluent in contact with the epidermal layer is a major contributing factor in the development of peristomal skin complications (PCS), this in turn can cause difficulty in adhesion of the baseplate to the affected skin, therefore further contributing to the future leaks.

To put an end to this cycle of worsening skin integrity and subsequent increased frequency of leaks, new leak sensor technology has been developed by Ulster University which can be used with any stoma pouch system to detect the early onset of stoma pouch failure - providing an alert that allows the patient to replace the pouch before catastrophic seepage of bowel/bladder content.

Whilst this new leak sensor technology will be extremely useful in the early detection of leaks, it is important to also consider how an individual's management of their stoma, as well as health and lifestyle behaviours, could be manipulated to further reduce the incidence of leaks and improve QoL. In a previous study, participants identified food consumption (i.e., eating certain foods) as being the most prominent contributor to the incidence of leaks. It has been reported that fruit and vegetables are avoided by ostomates - in particular those with an ileostomy - to help minimise the risk of leaks. Obviously, this is less than ideal, considering the well-established health benefits of consuming a diet rich in fruit and vegetables. At present, there is no evidence confirming the efficacy of restricting dietary intake to reduce the frequency of leaks. Therefore, it is possible that people living with a stoma are unnecessarily restricting their dietary intake and putting themselves at risk of various nutrient deficiencies and associated health conditions.

The over-riding aim of the current proposal is to validate a smart device that can be worn unobtrusively alongside existing stoma pouch systems whilst monitoring the condition of the adhesive skin wafer, such that erosion of the bond can be detected before a leak occurs. This would enable the wearer to replace the pouch avoiding the consequences of leakage and accompanying distress, therefore improving QoL and psychological well-being. The impact of the device on participant well-being will be assessed using a series of validated questionnaires. The sensor is not a medical device as it only interacts with the stoma bag and flange and does not interact directly with the participant or their bodily fluids.

The sensing device will:

  1. Accurately detect the onset of leaks.
  2. Provide a discrete personal alert (vibration).
  3. Allow for wireless connectivity for those requiring carer / nursing support.
  4. Allow for differences in patient dexterity; two distinct probe systems (microbutton or microwire sensor) will be validated.

Therefore, this study seeks to test the sensor technology with ileostomates in a cross over study involving microbutton and microwire sensors. This study hopes to achieve an 85% success rate in the accurate detection of leaks.

The secondary aim of this study is to determine associations between dietary intake and the incidence of leakages. This information will have the potential to inform the development of dietary guidelines for those living with a stoma, and to therefore improve overall nutritional status and health of this patient group.

Being tested
Stomasense
Keywords
Ileostomy, Stoma-pouch leakage, peristomal skin, dietary intake, quality of life

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • StomasenseDevice

    A smart device worn alongside stoma pouch systems which detects onset of a leak.

Study groups in NCT06914804
Study groupRoleWhat they receive
Leak detection device (microbutton probes)ExperimentalLeakage events will be detected by microbutton probes, which are attached to the sensing device
Receives: Device: Stomasense
Leak detection device (microwire probes)ExperimentalLeakage events will be detected by microwire probes, which are attached to the sensing device
Receives: Device: Stomasense

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Psychiatric morbidity

    Psychiatric morbidity will be assessed at the beginning and end of each test period using the General Health Questionnaire (GHQ-12).

    Measured: Comparison between treatments over a 2-week period.

  2. Psychological well-being

    Psychological well-being will be assessed at the beginning and end of each test period using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS)

    Measured: Comparison between treatments over a 2-week period.

  3. General quality of life

    General quality of life will be assessed at the beginning and end of each test period using the European Organization for Research and Treatment of Cancer (EORTC) QoL questionnaire for colorectal cancer (EORTCQLQ-CR38).

    Measured: Comparison between treatments over a 2-week period.

  4. General quality of life

    General quality of life will be assessed at the beginning and end of each test period using the The World Health Organization Quality of Life - BREF (WHOQOL-BREF).

    Measured: Comparison between treatments over a 2-week period.

  5. Stress and coping

    Stress and coping will be assessed at the beginning and end of each test period using the Perceived Stress Scale (PSS), which is a global measure of stress

    Measured: Change over 2 weeks comparison between treatments

  6. Resillience

    Resillience will be assessed at the beginning and end of each test period using the Connor-Davidson Resilience Scale (CD-RISC)

    Measured: Change over 2 weeks comparison between treatments

  7. Stoma related quality of life

    Stoma related quality of life will be assessed at the beginning and end of each test period using the Stoma QoL: A Quality-of-Life Questionnaire for People with an Ostomy

    Measured: Comparison between treatments over a 2-week period.

Secondary outcomes (4)
  1. Device accuracy

    Participants will keep a daily leak diary in which the incidence of leaks will be recorded. Participants will log leakage events as true positive (TP; successful detection of leak), false positive (FP; sensor alert but no leak occurred) or false negative (FN; occurrence of leak but no alert from device).

    Measured: Measured over 2 weeks comparison between treatments

  2. Device usability

    Participants will complete a user experience survey at the end of each treatment period.

    Measured: Measured at 2 weeks comparison between treatments

  3. Dietary intake

    Participants will complete 4-day food diaries at the beginning and end of each treatment period.

    Measured: Measured over 2 weeks comparison between treatments

  4. Peristomal skin condition

    Participants will complete a short questionnaire which evaluates peristomal skin condition at the beginning and end of each treatment period.

    Measured: Comparison between treatments over a 2-week period.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2025
  2. Study start14 Apr 2025 (estimated)
  3. Primary completion31 Jan 2026 (estimated)
  4. Study completion31 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06914804
Sponsor's protocol ID
UUREC/24/0074
Other IDs
MR W029561
Status last verified
Mar 2025
First submitted
26 Mar 2025
Last updated
6 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Stomasense in people with Ileostomy - Stoma, run by University of Ulster at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 6 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Psychiatric morbidity (time frame: Comparison between treatments over a 2-week period.). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in